Trial Details
RecruitingBasic Information
| Clinical ID | c5031 |
|---|---|
| Identifier | IRCT20220409054467N3 |
| Trial Title | Effects of Adalimumab in Iranian Pediatric with Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Inflammatory bowel disease. Inflammatory polyps of colon with intestinal obstruction;K51.412 |
| Interventions | Intervention group: Administration of adalimumab (40 mg/0.8 ml) which is injected in patients weighing less than 40 kg based on the following dose: 80 mg first, 40 mg two weeks later, 20 mg two weeks after the second dose and then depending on the respons |
Participant Information
| Sponsor | Tehran University of Medical Sciences |
|---|---|
| City | NULL |
| Country/Region | Iran |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, CHILD, TEENAGER |
Study Design
| Study Type | interventional |
|---|---|
| Phase | NULL |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |